Lower HCV Treatment Costs May Be In Sight

With recent debates on the cost of ‪#‎HCV‬ treatment, researchers may have found a way to reduce costs for direct acting antiviral medication by finding out when therapy can be safely discontinued.

Researchers have designed a model to use blood tests and therapy performance to determine a safe point for patients to safely stop treatments, reducing the costs and time of therapy. 

blog.avella.com/hepatitis-n...

oldestnewest

You may also like...